Roselyne Tournaire

Title: Innovations of Roselyne Tournaire in Angiogenesis Research

Introduction

Roselyne Tournaire is a prominent inventor based in La Gaude, France. She has made significant contributions to the field of biomedical research, particularly in the area of angiogenesis. Her work focuses on developing innovative solutions to combat diseases related to abnormal blood vessel growth.

Latest Patents

Roselyne Tournaire holds a patent for her invention titled "Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof." This patent describes peptides that can interact with VEGF, inhibiting its interaction with KDR or anti-VEGF antibodies. This inhibition is crucial for preventing VEGF-mediated angiogenesis and related diseases. The invention also includes polynucleotides encoding these peptides, vectors containing the polynucleotides, and pharmaceutical compositions that utilize these peptides for therapeutic purposes.

Career Highlights

Roselyne Tournaire is affiliated with the prestigious Institut Pasteur, where she conducts her research. Her work has garnered attention for its potential applications in treating various angiogenesis-related conditions. With her innovative approach, she has positioned herself as a key figure in the field of vascular biology.

Collaborations

Roselyne collaborates with esteemed colleagues, including Caroline Demangel and Claude Derbin. These partnerships enhance her research efforts and contribute to the advancement of knowledge in the field.

Conclusion

Roselyne Tournaire's contributions to angiogenesis research through her innovative patents and collaborations highlight her role as a leading inventor in the biomedical field. Her work continues to pave the way for new therapeutic strategies against diseases associated with abnormal blood vessel growth.